The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
High‐grade prostate cancer is associated with low serum testosterone levels
Abstract
BACKGROUND: The aim of this study was to assess whether low serum testosterone levels in men with newly diagnosed prostate cancer have an association to the endocrine status, prostate‐specific antigen (PSA) levels, Gleason score, and androgen receptor expression. METHODS: Besides a full clinical work‐up, the following hormones were quantified in men with newly diagnosed prostate cancer by serum analysis: total testosterone, human luteinising hormone (hLH), human follicle stimulating hormone (hFSH), estradiol, and dehydroepiandrostendione (DHEA). In a subgroup of men, androgen receptor expression was determined immunohistochemically. RESULTS: One hundred and fifty six patients (65.7 ± 8.5 yrs) with a mean PSA of 29.8 ng/ml (median: 7.4 ng/ml) were analysed. Fifty‐two patients (33%) had a partial androgen deficiency (serum testosterone <3.0 ng/ml). These men had lower hLH (3.3 vs. 5.9 mIU/ml), hFSH (6.2 vs. 8.4 mIU/ml), and estradiol (18.8 vs. 29.1 pg/ml) serum levels. Mean Gleason score was higher (7.4 vs. 6.2) in men with a low serum testosterone, PSA‐levels were lower (25.3 vs. 31.9 ng/ml). Mean testosterone levels decreased from 4.1 ± 1.7 ng/ml in patients with Gleason scores ≤ 5 to 2.8 ± 2.7 ng/ml with Gleason scores ≥ 8. Androgen receptor expression was higher in patients with low serum testosterone. CONCLUSIONS: Patients with high Gleason score prostate cancer have lower testosterone and estradiol serum levels. The fact that gonadotropins were lower in parallel suggests a tumor‐mediated suppression of the hypothalamic‐pituitary‐gonadal hormone axis particularly in men with high Gleason score tumours. Prostate 47:52–58, 2001. © 2001 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER?
HOFFMAN, M. A., DeWOLF, W. C., & MORGENTALER, A. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67812-3 · Cited by 322
Occult Prostate Cancer in Men With Low Serum Testosterone Levels
Morgentaler, A. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540230054035 · Cited by 279
INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM HORMONE LEVELS
MILLER, L. R., PARTIN, A. W., CHAN, D. W., BRUZEK, D. J., DOBS, A. S., EPSTEIN, J. I., & WALSH, P. C. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62922-7 · Cited by 177
What causes prostate cancer? A brief summary of the epidemiology
Chan, J. M., Stampfer, M. J., & Giovannucci, E. L. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0075 · Cited by 141
Longitudinal evaluation of serum androgen levels in men with and without prostate cancer
Carter, H. B., Pearson, J. D., Metter, E. J., Chan, D. W., Andres, R., Fozard, J. L., Rosner, W., & Walsh, P. C. (1995) · The Prostate · doi:10.1002/pros.2990270106 · Cited by 138
Prediagnostic serum hormones and the risk of prostate cancer.
Nomura, A. M. Y., Heilbrun, L. K., Stemmermann, G. N., & Judd, H. L. (1988) · PubMed · Cited by 129
Schatzl, G., Brössner, C., Schmid, S., Kugler, W., Roehrich, M., Treu, T. M., Szalay, A., Djavan, B., Schmidbauer, C. P., Söregi, S., et al. (2000) · Urology · doi:10.1016/s0090-4295(99)00473-2 · Cited by 129
Self-citationGenetic and Environmental Factors in Prostate Cancer Genesis:Identifying High-Risk Cohorts
Ekman, P. (1999) · European Urology · doi:10.1159/000019910 · Cited by 78
Andersson, S.-O., Adami, H., Bergström, R., & WIDE, L. E. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.293 · Cited by 60
Prediagnostic Serum Hormones and the Risk of Prostate Cancer
Nomura, A. M. Y., Heilbrun, L. K., Stemmermann, G. N., & Judd, H. L. (1989) · The Journal of Urology · doi:10.1016/s0022-5347(17)41092-5 · Cited by 32
Lukkarinen, O. A., Hammond, G. L., Kontturi, M. J., & Vihko, R. (1980) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365598009179566 · Cited by 21
Cited by
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Giovannucci, E., & Michaud, D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.050 · Cited by 543
Emmelot-Vonk, M. H., Verhaar, H. J. J., Nakhai Pour, H. R., Aleman, A., Lock, T. M. T. W., Bosch, J. L. H. R., Grobbee, D. E., & van der Schouw, Y. T. (2008) · JAMA · doi:10.1001/jama.2007.51 · Cited by 518
Rodriguez, C., Freedland, S. J., Deka, A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Thun, M. J., & Calle, E. E. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0754 · Cited by 354
Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
Gong, Z., Neuhouser, M. L., Goodman, P. J., Albanes, D., Chi, C., Hsing, A. W., Lippman, S. M., Platz, E. A., Pollak, M. N., Thompson, I. M., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0477 · Cited by 352
Metadata
- Authors
- Schatzl, G., Madersbacher, S., Thurridl, T., Waldmüller, J., Kramer, G., Haitel, A., & Marberger, M.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2001-03-21
- Volume
- 47
- Issue
- 1
- Pages
- 52-58
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2032165027
- Cited by
- 334
- References
- 13
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.